Incidence of cardiovascular events in italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments

Giovanni Corrao, Antonella Zambon, Andrea Parodi, Luca Merlino, Giuseppe Mancia

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Aim of the present investigation was to quantify the early discontinuation phenomenon in patients treated for hypertension, dyslipidemia or diabetes, and to assess their clinical characteristics and incidence of cardiovascular (CV) outcomes to see whether an incorrect diagnosis was involved or treatment continuation might have been indicated. Methods Using the health-care databases on beneficiaries of the National Health Service (NHS) living in Lombardy, we studied patients aged 40-79 years who received their first prescription during 2003. Patients were classified according to whether they received only one or multiple prescriptions and data were compared with those obtained in individuals who did not receive any prescription. Crude and standardized rates of hospitalization for CV outcomes were calculated from initial prescription until 2008. Results Among the 203,302 patients on antihypertensive therapy, those experiencing only one prescription (35.7%) showed significant higher rates of cotreatments, comorbidities, and CV hospitalization than those who did not receive antihypertensive medications. Standardized CV rates were respectively 40.0 and 37.8 events every 10,000 person-year at risk (+7%). Similar findings were obtained for antidiabetic or lipid-lowering medications for which the between-group difference in CV rate was even greater (+21% and 18% respectively). Conclusions In general practice management of hypertension, dyslipidemia and diabetes is characterized by a high rate of treatment discontinuation. Patients who early discontinued had an unfavorable risk profile and a greater incidence of CV events than untreated patients. This suggests that they include candidates in whom treatment continuation is advisable.

Original languageEnglish
Pages (from-to)549-555
Number of pages7
JournalAmerican Journal of Hypertension
Volume25
Issue number5
DOIs
Publication statusPublished - May 2012

Fingerprint

Hypoglycemic Agents
Antihypertensive Agents
Prescriptions
Lipids
Incidence
Dyslipidemias
Hospitalization
Therapeutics
Hypertension
Practice Management
National Health Programs
General Practice
Comorbidity
Databases
Delivery of Health Care

Keywords

  • antidiabetic medication
  • antihypertensive medication
  • blood pressure
  • cardiovascular outcome
  • database
  • hypertension
  • lipid-lowering agents
  • record linkage
  • treatment discontinuation

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Incidence of cardiovascular events in italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments. / Corrao, Giovanni; Zambon, Antonella; Parodi, Andrea; Merlino, Luca; Mancia, Giuseppe.

In: American Journal of Hypertension, Vol. 25, No. 5, 05.2012, p. 549-555.

Research output: Contribution to journalArticle

Corrao, Giovanni ; Zambon, Antonella ; Parodi, Andrea ; Merlino, Luca ; Mancia, Giuseppe. / Incidence of cardiovascular events in italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments. In: American Journal of Hypertension. 2012 ; Vol. 25, No. 5. pp. 549-555.
@article{1c1ffeaa1de042cb8274b402c6930e33,
title = "Incidence of cardiovascular events in italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments",
abstract = "Background Aim of the present investigation was to quantify the early discontinuation phenomenon in patients treated for hypertension, dyslipidemia or diabetes, and to assess their clinical characteristics and incidence of cardiovascular (CV) outcomes to see whether an incorrect diagnosis was involved or treatment continuation might have been indicated. Methods Using the health-care databases on beneficiaries of the National Health Service (NHS) living in Lombardy, we studied patients aged 40-79 years who received their first prescription during 2003. Patients were classified according to whether they received only one or multiple prescriptions and data were compared with those obtained in individuals who did not receive any prescription. Crude and standardized rates of hospitalization for CV outcomes were calculated from initial prescription until 2008. Results Among the 203,302 patients on antihypertensive therapy, those experiencing only one prescription (35.7{\%}) showed significant higher rates of cotreatments, comorbidities, and CV hospitalization than those who did not receive antihypertensive medications. Standardized CV rates were respectively 40.0 and 37.8 events every 10,000 person-year at risk (+7{\%}). Similar findings were obtained for antidiabetic or lipid-lowering medications for which the between-group difference in CV rate was even greater (+21{\%} and 18{\%} respectively). Conclusions In general practice management of hypertension, dyslipidemia and diabetes is characterized by a high rate of treatment discontinuation. Patients who early discontinued had an unfavorable risk profile and a greater incidence of CV events than untreated patients. This suggests that they include candidates in whom treatment continuation is advisable.",
keywords = "antidiabetic medication, antihypertensive medication, blood pressure, cardiovascular outcome, database, hypertension, lipid-lowering agents, record linkage, treatment discontinuation",
author = "Giovanni Corrao and Antonella Zambon and Andrea Parodi and Luca Merlino and Giuseppe Mancia",
year = "2012",
month = "5",
doi = "10.1038/ajh.2011.261",
language = "English",
volume = "25",
pages = "549--555",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Incidence of cardiovascular events in italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments

AU - Corrao, Giovanni

AU - Zambon, Antonella

AU - Parodi, Andrea

AU - Merlino, Luca

AU - Mancia, Giuseppe

PY - 2012/5

Y1 - 2012/5

N2 - Background Aim of the present investigation was to quantify the early discontinuation phenomenon in patients treated for hypertension, dyslipidemia or diabetes, and to assess their clinical characteristics and incidence of cardiovascular (CV) outcomes to see whether an incorrect diagnosis was involved or treatment continuation might have been indicated. Methods Using the health-care databases on beneficiaries of the National Health Service (NHS) living in Lombardy, we studied patients aged 40-79 years who received their first prescription during 2003. Patients were classified according to whether they received only one or multiple prescriptions and data were compared with those obtained in individuals who did not receive any prescription. Crude and standardized rates of hospitalization for CV outcomes were calculated from initial prescription until 2008. Results Among the 203,302 patients on antihypertensive therapy, those experiencing only one prescription (35.7%) showed significant higher rates of cotreatments, comorbidities, and CV hospitalization than those who did not receive antihypertensive medications. Standardized CV rates were respectively 40.0 and 37.8 events every 10,000 person-year at risk (+7%). Similar findings were obtained for antidiabetic or lipid-lowering medications for which the between-group difference in CV rate was even greater (+21% and 18% respectively). Conclusions In general practice management of hypertension, dyslipidemia and diabetes is characterized by a high rate of treatment discontinuation. Patients who early discontinued had an unfavorable risk profile and a greater incidence of CV events than untreated patients. This suggests that they include candidates in whom treatment continuation is advisable.

AB - Background Aim of the present investigation was to quantify the early discontinuation phenomenon in patients treated for hypertension, dyslipidemia or diabetes, and to assess their clinical characteristics and incidence of cardiovascular (CV) outcomes to see whether an incorrect diagnosis was involved or treatment continuation might have been indicated. Methods Using the health-care databases on beneficiaries of the National Health Service (NHS) living in Lombardy, we studied patients aged 40-79 years who received their first prescription during 2003. Patients were classified according to whether they received only one or multiple prescriptions and data were compared with those obtained in individuals who did not receive any prescription. Crude and standardized rates of hospitalization for CV outcomes were calculated from initial prescription until 2008. Results Among the 203,302 patients on antihypertensive therapy, those experiencing only one prescription (35.7%) showed significant higher rates of cotreatments, comorbidities, and CV hospitalization than those who did not receive antihypertensive medications. Standardized CV rates were respectively 40.0 and 37.8 events every 10,000 person-year at risk (+7%). Similar findings were obtained for antidiabetic or lipid-lowering medications for which the between-group difference in CV rate was even greater (+21% and 18% respectively). Conclusions In general practice management of hypertension, dyslipidemia and diabetes is characterized by a high rate of treatment discontinuation. Patients who early discontinued had an unfavorable risk profile and a greater incidence of CV events than untreated patients. This suggests that they include candidates in whom treatment continuation is advisable.

KW - antidiabetic medication

KW - antihypertensive medication

KW - blood pressure

KW - cardiovascular outcome

KW - database

KW - hypertension

KW - lipid-lowering agents

KW - record linkage

KW - treatment discontinuation

UR - http://www.scopus.com/inward/record.url?scp=84859911372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859911372&partnerID=8YFLogxK

U2 - 10.1038/ajh.2011.261

DO - 10.1038/ajh.2011.261

M3 - Article

VL - 25

SP - 549

EP - 555

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 5

ER -